250 related articles for article (PubMed ID: 29045704)
1. New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?
Santos AH; Chen C; Casey MJ; Womer KL; Wen X
Nephrol Dial Transplant; 2018 Jan; 33(1):177-184. PubMed ID: 29045704
[TBL] [Abstract][Full Text] [Related]
2. Association of Baseline Viral Serology and Sirolimus Regimens With Kidney Transplant Outcomes: A 14-Year Registry-Based Cohort Study in the United States.
Santos AH; Casey MJ; Xuerong W; Womer KL
Transplantation; 2017 Feb; 101(2):377-386. PubMed ID: 28121742
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of sirolimus regimens in 65-year-old and older kidney transplant recipients: a registry-based observational study.
Santos AH; Chen C; Alquadan K; Wen X
Int Urol Nephrol; 2019 Nov; 51(11):2063-2072. PubMed ID: 31385180
[TBL] [Abstract][Full Text] [Related]
4. Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and coinfection on the development of new-onset diabetes after kidney transplantation.
Liang J; Lv C; Chen M; Xu M; Zhao C; Yang Y; Wang J; Zhu D; Gao J; Rong R; Zhu T; Yu M
J Diabetes; 2019 May; 11(5):370-378. PubMed ID: 30203544
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
[TBL] [Abstract][Full Text] [Related]
6. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
Transplantation; 2012 Jan; 93(1):73-81. PubMed ID: 22129761
[TBL] [Abstract][Full Text] [Related]
7. Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study.
Rathi M; Rajkumar V; Rao N; Sharma A; Kumar S; Ramachandran R; Kumar V; Kohli HS; Gupta KL; Sakhuja V
Transplant Proc; 2015 May; 47(4):1158-61. PubMed ID: 26036543
[TBL] [Abstract][Full Text] [Related]
8. Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens.
Felix MJ; Felipe CR; Tedesco-Silva H; Osmar Medina-Pestana J
Pharmacotherapy; 2016 Feb; 36(2):152-65. PubMed ID: 26799522
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimens.
Gyurus E; Kaposztas Z; Kahan BD
Transplant Proc; 2011 Jun; 43(5):1583-92. PubMed ID: 21693238
[TBL] [Abstract][Full Text] [Related]
10. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
11. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus/sirolimus versus tacrolimus/mycophenolate in kidney transplantation: improved 3-year graft and patient survival in recent era.
Gralla J; Wiseman AC
Transplantation; 2009 Jun; 87(11):1712-9. PubMed ID: 19502965
[TBL] [Abstract][Full Text] [Related]
13. New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression.
Luan FL; Steffick DE; Ojo AO
Transplantation; 2011 Feb; 91(3):334-41. PubMed ID: 21242885
[TBL] [Abstract][Full Text] [Related]
14. Prospective observational study of sirolimus as primary immunosuppression after renal transplantation.
Pescovitz MD; Nezakatgoo N; Lorber MI; Nashan B; Tedesco-Silva H; Kasiske BL; de la Cruz FJ; Russ G; Campistol J; Keown PA;
Transplantation; 2009 Oct; 88(8):1010-8. PubMed ID: 19855247
[TBL] [Abstract][Full Text] [Related]
15. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
[TBL] [Abstract][Full Text] [Related]
16. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation.
Van Laecke S; Desideri F; Geerts A; Van Vlierberghe H; Berrevoet F; Rogiers X; Troisi R; de Hemptinne B; Vanholder R; Colle I
Liver Transpl; 2010 Nov; 16(11):1278-87. PubMed ID: 21031543
[TBL] [Abstract][Full Text] [Related]
17. Is there a genetic predisposition to new-onset diabetes after kidney transplantation?
Reddy YN; Abraham G; Sundaram V; Reddy PP; Mathew M; Nagarajan P; Mehra N; Ramachandran A; Ali AA; Reddy YN
Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1113-20. PubMed ID: 26586047
[TBL] [Abstract][Full Text] [Related]
18. Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period.
Luan FL; Zhang H; Schaubel DE; Miles CD; Cibrik D; Norman S; Ojo AO
Am J Transplant; 2008 Sep; 8(9):1871-7. PubMed ID: 18786231
[TBL] [Abstract][Full Text] [Related]
19. Impact of low-dose steroids on HbA1c levels and development of pre-diabetes and NODAT in non-diabetic renal transplant recipients on long-term follow-up.
Tillmann FP; Schmitz M; Rump LC; Quack I
Int Urol Nephrol; 2018 Apr; 50(4):771-777. PubMed ID: 29197933
[TBL] [Abstract][Full Text] [Related]
20. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
